<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2016 (10) TMI 1337 - Supreme Court</title>
    <link>https://www.taxtmi.com/caselaws?id=296522</link>
    <description>The article examines delegated price-control under the Drugs (Prices Control) Order, 1995 and explains that expert-based norms for conversion cost, packing charges and process loss were treated as valid when supported by available material and not shown to be arbitrary. It also discusses that yearly re-determination of those norms was not regarded as mandatory where the underlying data remained unchanged and industry non-cooperation prevented a fresh study. The text further notes that retail or ceiling price fixation could proceed without a separately prescribed packing material norm and without first fixing a bulk drug price, because the scheme did not make bulk-drug pricing a pre-condition for formulation pricing. Judicial review is described as limited to application of the statutory formula on relevant material.</description>
    <language>en-us</language>
    <pubDate>Fri, 21 Oct 2016 00:00:00 +0530</pubDate>
    <lastBuildDate>Mon, 26 Jul 2021 09:13:32 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=650658" rel="self" type="application/rss+xml"/>
    <item>
      <title>2016 (10) TMI 1337 - Supreme Court</title>
      <link>https://www.taxtmi.com/caselaws?id=296522</link>
      <description>The article examines delegated price-control under the Drugs (Prices Control) Order, 1995 and explains that expert-based norms for conversion cost, packing charges and process loss were treated as valid when supported by available material and not shown to be arbitrary. It also discusses that yearly re-determination of those norms was not regarded as mandatory where the underlying data remained unchanged and industry non-cooperation prevented a fresh study. The text further notes that retail or ceiling price fixation could proceed without a separately prescribed packing material norm and without first fixing a bulk drug price, because the scheme did not make bulk-drug pricing a pre-condition for formulation pricing. Judicial review is described as limited to application of the statutory formula on relevant material.</description>
      <category>Case-Laws</category>
      <law>Indian Laws</law>
      <pubDate>Fri, 21 Oct 2016 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=296522</guid>
    </item>
  </channel>
</rss>